Counter-regulatory hormones and mechanisms in amino acid metabolism with special reference to the catabolic response in skeletal muscle

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 2, Issue 1, 1999, Pages 9-14

  Hasselgren, Per Olof ^a   Fischer, Josef E ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTOKINE; GLUCOCORTICOID;

ANIMAL; HUMAN; INJURY; METABOLISM; NEUROSECRETION; PHYSIOLOGY; REVIEW; SEPSIS; SKELETAL MUSCLE; TRANSPORT AT THE CELLULAR LEVEL;

AMINO ACIDS; ANIMALS; BIOLOGICAL TRANSPORT; CYTOKINES; GLUCOCORTICOIDS; HUMANS; MUSCLE, SKELETAL; NEUROSECRETORY SYSTEMS; SEPSIS;

EID: 0032601957     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-199901000-00003     Document Type: Article

References (50)

1. Hasselgren PO. Mediators, hormones, and control of metabolism: regulation of protein, carbohydrate, and lipid metabolism in critical illness. In: Nutrition and metabolism in the surgical patient, 2nd edn. Fischer JE (editor). Boston: Little, Brown and Co; 1996. pp. 57-104.
2. Del Rey A, Basedovsky HO. Metabolic and neuroendocrine effects of proinflammatory cytokines. Eur J Clin Invest 1992; 22:10-15.
3. Zamir O, Hasselgren PO, Higashiguchi T, Frederick JA, Fischer JE. Tumor necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms. Mediators Inflamm 1992; 1:247-250.
4. Hasselgren PO. Counter-regulatory hormones and the role of cytokines in the control of amino acid metabolism. In: Amino acid metabolism and therapy in health and nutritional disease. Cynober LA (editor). Boca Raton, FL: CRC Press; 1995. pp. 139-156.
5. Hasselgren PO, James JH, Benson DW, Hall-Angers M, Angerås U, Hiyama DT, et al. Total and myofibrillar protein breakdown in different types of rat skeletal muscle: effects of sepsis and regulation by insulin. Metabolism 1989; 38:634-640.
6. Tiao GM, Fagan JM, Samuels N, James JH, Hudson K, Lieberman M, et al. Sepsis stimulates non-lysosomal energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J Clin Invest 1994; 94:2255-2264.
7. Tiao G, Hobler S, Wang JJ, Meyer TA, Luchette FA, Fischer JE, Hasselgren PO. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest 1997; 99:163-168.
8. 2+-dependent release of myofilaments increases in skeletal muscle during sepsis. Surg Forum 1998; 49:66-69.
9. Karlstad MD, Sayeed MM. α-Amino isobutyric acid transport in rat soleus muscle during endotoxemic shock. Am J Physiol 1985; 248:R142-146.
10. Karlstad MD, Sayeed MM. Effect of endotoxemic shock on kinetics of system A amino acid transport in rat soleus muscle. Am J Physiol 1986; 251:R150-156.
11. Hasselgren PO, James JH, Fischer JE. Inhibited muscle amino acid uptake in sepsis. Ann Surg 1986; 203:360-365.
12. Hasselgren PO, James JH, Warner BW, Ogle CK, Takehara H, Fischer JE. Reduced muscle amino acid uptake in sepsis and the effects in vitro of septic plasma and interleukin-1. Surgery 1986; 100:222-228.
13. Roth E, Furnovics J, Mülbacher F, Schemper M, Mauritz W, Sporn P, Fritsch A. Metabolic disorders in severe abdominal sepsis: glutamine deficiency in skeletal muscle. Clin Nutr 1982; 1:25-41.
14. Ardawi MSM, Majroub MF. Glutamine metabolism in skeletal muscle of septic rats. Metabolism 1991; 40:155-164.
15. Austgen TR, Chakrabarti R, Chen MK, Souba WW. Adaptive regulation in skeletal muscle of glutamine metabolism in endotoxin-treated rats. J Trauma 1992; 32:600-606.
16. Newsholme EA, Parry-Billings M. Properties of glutamine release from muscle and its importance for the immune system. J Parenter Enter Nutr 1990; 14:63S-67.
17. MacLennan PA, Brown RA, Rennie MJ. A positive relationship between protein synthetic rate and intracellular glutamine concentration in perfused rat skeletal muscle. FEBS Lett 1987; 215:187-191.
18. MacLennan PA, Smith K, Weryk B, Watt PW, Rennie MJ. Inhibition of protein breakdown by glutamine in perfused rat skeletal muscle. FEBS Lett 1988; 237:133-136.
19. Hall-Angerås M, Angerås U, Zamir O, Hasselgren PO, Fischer JE. Effect of the glucocorticoid receptor antagonist RU38486 on muscle protein breakdown in sepsis. Surgery 1991; 109:468-473.
20. Tiao G, Fagan J, Roegner V, Lieberman M, Wang JJ, Fischer JE, Hasselgren PO. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest 1996; 97:339-348.
21. Darmann D, Mathews DE, Bier DM. Physiological hypercortisolemia increases proteolysis, glutamine and alanine production. Am J Physiol 1988; 255:E366-373.
22. McGrath JA, Goldspink DF. Glucocorticoid action on protein synthesis and protein breakdown in isolated skeletal muscles. Biochem J 1982; 206:641-645.
23. Wang L, Luo GJ, Wang JJ, Hasselgren PO. Dexamethasone stimulates proteasome- and calcium-dependent proteolysis in cultured L6 myotubes. Shock 1998; 10:298-306.
24. Wing SS, Goldberg AL. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am J Physiol 1993; 264:E668-676.
25. Fang CH, James JH, Ogle C, Fischer JE, Hasselgren PO. Influence of burn injury on protein metabolism in different types of skeletal muscle and the role of glucocorticoids. J Am Coll Surg 1995; 180:33-42.
26. Price SR, England BK, Bailey L, VanVrede K, Mitch WE. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. Am J Physiol 1994; 267:C955-960.
27. Mühlbacher F, Kapadia CR, Colpoys MF, Smith RJ, Wilmore DW. Effects of glucocorticoids on glutamine metabolism in skeletal muscle. Am J Physiol 1984; 247:E75-83.
28. Parry-Billings M, Leighton B, Dimitriadis GD, Borell J, Newsholme EA. Effects of physiological and pathological levels of glucocorticoids on skeletal muscle glutamine metabolism in the rat. Biochem Pharmacol 1990; 40:1145-1148.
29. Hundal HS, Babij P, Taylor PM, Watt PW, Rennie MJ. Effects of corticosteroid on the transport and metabolism of glutamine in rat skeletal muscle. Biochim Biophys Acta 1991; 1092:376-383.
30. Max SR, Thomas JW, Banner C, Vitkovic L, Konagaya M, Konagaya Y. Glucocorticoid receptor-mediated induction of glutamine synthetase in skeletal muscle cells in vitro. Endocrinology 1987; 120:1179-1183.
31. Max SR, Mill J, Mearow K, Konagaya M, Konagaya Y, Thomas JW, et al. Dexamethasone regulates glutamine synthetase expression in rat skeletal muscles. Am J Physiol 1988; 255:E397-402.
32. Lewis SEM, Goldspink DF. The influence of cortisol on amino acid transport in rat skeletal muscle. Biochem Soc Trans 1982; 10:170-175.
33. Warner BW, James JH, Hasselgren PO, LaFrance R, Fischer JE. Effect of catabolic hormone infusion on organ amino acid uptake. J Surg Res 1987; 42:418-424.
34. Warner BW, Hasselgren PO, Hummel RP, James JH, Pedersen P, Fischer JE. Effect of catabolic hormone infusion on protein turnover and amino acid uptake in skeletal muscle. Am J Surg 1990; 159:295-300.
35. Zamir O, James JH, Hasselgren PO, Fischer JE. Evidence that inhibition of muscle amino acid uptake during endotoxemia is not mediated by glucocorticoids. Metabolism 1993; 42:1190-1194.
36. Zamir O, Hasselgren PO, Kunkel SL, Frederick JA, Higashiguchi T, Fischer JE. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch Surg 1992; 127:170-174.
37. Zamir O, O'Brien W, Thompson R, Bloedow DC, Fischer JE, Hasselgren PO. Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist. Int J Biochem 1994; 26:943-950.
38. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GG, Istfan NW. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin-1. J Clin Invest 1989; 83:1614-1622.
39. Mealey K, van Lanschot JJB, Robinson BG, Ramos J, Wilmore DW. Are the catabolic effects of tumor necrosis factor mediated by glucocorticoids? Arch Surg 1990; 125:42-48.
40. Tsujinaka T, Ebisui C, Fujita J, Kishibachi M, Marimoto T, Ogana A, et al. Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse. Biochem Biophys Res Commun 1995; 207:168-174.
41. Garcia-Martinez C, Lopez-Soriano FJ, Argiles JM. Interleukin-6 does not activate protein breakdown in rat skeletal muscle. Cancer Lett 1994; 76:1-4.
42. Williams AB, Wang JJ, Wang L, Sun X, Fischer JE, Hasselgren PO. Sepsis in mice stimulates muscle proteolysis in the absence of IL-6. Am J Physiol 1998; in press.
43. Starnes HF, Warren RS, Conti PS, Calvano SE, Brennan MF. Redistribution of amino acids in rat liver and muscle induced by tumor necrosis factor requires the adrenal response. Surg Forum 1987; 38:41-42.
44. Zamir O, Hasselgren PO, James JH, Higashiguchi T, Fischer JE. Effect of tumor necrosis factor or interleukin-1 on muscle amino acid uptake and the role of glucocorticoids. Surg Gynecol Obset 1993; 177:27-32.
45. Hummel RP, Warner BW, Pedersen P, Hasselgren PO, James JH, Ogle C, Fischer JE. In vitro effects of TNF, IL-1α, and other monokines on skeletal muscle amino acid uptake and protein degradation. Surg Forum 1987; 38:13-15.
46. De Blaauw I, Eggermont AMM, Deutz NEP, deVries M, Buurman WA, von Meyenfeldt MF. TNF-α has no direct in vivo metabolic effect on human muscle. Int J Cancer 1997; 71:148-154. Although the results in this study suggest that the infusion of TNF does not stimulate protein breakdown and the release of amino acids from skeletal muscle, the results need to be interpreted with caution because TNF was infused in tumor-bearing limbs. It is possible that the presence of the malignant tumor had already induced changes in amino acid release and metabolism and had altered the responsiveness to TNF-α of muscle protein and amino acid metabolism.
47. Tracey KJ, Lowry SF, Beutler B, Cerami A, Albert JD, Shires GT. Cachectin/ tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential. J Exp Med 1986; 164:1368-1373.
48. Fang CH, Li BG, James JH, Fischer JE, Hasselgren PO. Cytokines block the effects of insulin-like growth factor-I (IGF-I) on glucose uptake and lactate production in skeletal muscle but do not influence IGF-I-induced changes in protein turnover. Shock 1997; 8:362-367.
49. Chakrabarti R. Transcriptional regulation of the rat glutamine synthetase gene by tumor necrosis factor-α. Eur J Biochem 1998; 254:70-74. Important results that suggest that TNF may have a direct effect on skeletal muscle glutamine metabolism.
50. Hack V, Gross A, Kinscherf R, Bockstette M, Fiers W, Berke G, et al. Abnormal glutathione and sulfate levels after interleukin-6 treatment and in tumor-induced cachexia. FASEB J 1996; 10:1219-1226.